Synthesis of an Artificial gp41-C34 Trimer as an HIV-1 Fusion Inhibitor
Chie Hashimoto, Wataru Nomura, A Komano Jun, Hirokazu Tamamura
Abstract
Chie Hashimoto, Wataru Nomura, A Komano Jun, Hirokazu Tamamura
Abstract
The trimer form of the human immunodeficiency virus type a (HIV-1) envelope protein gp41 plays pivotal role in HIV-1 entry. The gp41 is composed with trimers of the N-terminal and C-terminal helical region (NHR and CHR), which form a six-helical bundle (6HB) in the membrane fusion step. A trimeric peptide was synthesized using a C34 derived from CHR using a newly designed template with three equivalent linkers. The C34 trimer induced neutralizing antibodies which can recognize the structure of the C34 trimer. Besides, the C34 trimer showed 100-fold unexpectedly higher anti-HIV-1 activity than the C34 monomer, indicating that a trimeric form is critical for its inhibitory activity.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The trimer form of the human immunodeficiency virus type a (HIV-1) envelope protein gp41 plays pivotal role in HIV-1 entry. The gp41 is composed with trimers of the N-terminal and C-terminal helical region (NHR and CHR), which form a six-helical bundle (6HB) in the membrane fusion step. A trimeric peptide was synthesized using a C34 derived from CHR using a newly designed template with three equivalent linkers. The C34 trimer induced neutralizing antibodies which can recognize the structure of the C34 trimer. Besides, the C34 trimer showed 100-fold unexpectedly higher anti-HIV-1 activity than the C34 monomer, indicating that a trimeric form is critical for its inhibitory activity.
Key concepts: Trimer, Gp41, Chemistry, Lipid bilayer fusion, Stereochemistry, Human immunodeficiency virus (HIV), Antibody, Biochemistry